Ocular and Systemic Safety of a Recombinant AAV8 Vector for X-Linked Retinoschisis Gene Therapy: GLP Studies in Rabbits and Rs1-Ko Mice

Molecular Therapy - Methods and Clinical Development - United States
doi 10.1038/mtm.2016.11
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Preclinical Safety Evaluation of a Recombinant AAV8 Vector for X-Linked Retinoschisis After Intravitreal Administration in Rabbits

Human gene therapy. Clinical development
Genetics
2014English

Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2020English

Assessment of Toxicity and Biodistribution of Recombinant AAV8 Vector–mediated Immunomodulatory Gene Therapy in Mice With Pompe Disease

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Multimodal Imaging in a Pedigree of X-Linked Retinoschisis With a Novel RS1 Variant

BMC Medical Genetics
Genetics
2018English

Cog-Wheel Octameric Structure of RS1, the Discoidin Domain Containing Retinal Protein Associated With X-Linked Retinoschisis

PLoS ONE
Multidisciplinary
2016English

Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

174. Liver Fibrosis in Aged OTC-KO Heterozygotes and Successful Correction by AAV8-Mediated Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Bullous X Linked Retinoschisis: Clinical Features and Prognosis

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2017English

Retinal Function in X-Linked Juvenile Retinoschisis

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy